Discover 1,482 paid clinical trials in Greeley, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,482
Active & Responsive
Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
for
Opioid Use Disorder
Location: Denver CO, Minneapolis MN, Oakland CA, San Francisco CA,
Sponsor: Yale University
Sex: All
Age: 18 - 70+
Code: NCT06323824
Recruiting
Active & Responsive
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Denver CO, Salt Lake City UT, Tucson AZ, Dallas TX,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05216432
Phase 1, Recruiting
Active & Responsive
Device Global Registry for the IlluminOss Bone Stabilization System
for
Traumatic Fracture, Pathological Fracture
Location: Denver CO, Los Angeles CA, Katy TX, Pittsburgh PA,
Sponsor: IlluminOss Medical, Inc.
Sex: All
Age: 50+
Code: NCT05206981
Recruiting
Active & Responsive
FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors
for
Solid Tumor
Location: Denver CO, Portland OR, Charleston SC, New Haven CT
Sponsor: Axcynsis Therapeutics Pte Ltd
Sex: All
Age: 18+
Code: NCT06809114
Phase 1, Recruiting
Active & Responsive
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
for
Advanced Solid Cancers
Location: Denver CO, Detroit MI, Orlando FL, New York NY
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07186842
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
for
Primary Myelofibrosis (PMF),
Location: Denver CO, Dallas TX, Tyler TX, Austin TX, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07357727
Phase 3, Recruiting
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension